NIH Ousts Key Director

WASHINGTON--The National Institutes of Health has removed the head of the office that buys supplies and equipment for its intramural research program following a stinging government report that found widespread mismanagement of the federal fund being spent on supplies and equipment. A five-year battle between NIH and its parent, the Department of Health and Human Services, culminated last month in the replacement of Edwin ("Ted") Becker as director of NIH’s Office of Research Services

Written byJeffrey Mervis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A five-year battle between NIH and its parent, the Department of Health and Human Services, culminated last month in the replacement of Edwin ("Ted") Becker as director of NIH’s Office of Research Services (ORS). Last year the office was responsible for the purchase of some $174 million worth of items for both the main campus in Bethesda, Md., and affiliated laboratories around the country.

The last straw was an April 15 letter from Richard Kusserow, the department’s inspector general, to HHS Secretary Otis Bowen. In it, Kusserow charged that "there is a major failure in internal controls at ORS . . . which is resulting in $26 million in precious research funds being lost each year due to ineffi- ciency and mismanagement."He added: "Prompt and decisive action is needed to root out these long-standing, systemic procurement deficiencies."

NIH has long resisted such criticism. A report accompanying Kusserow’s letter cites findings ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies